Abstract
Skeletal muscle decellularization allows the generation of natural scaffolds that retain the extracellular matrix (ECM) mechanical integrity, biological activity, and three‐dimensional (3D) architecture of the native tissue. Recent reports showed that in vivo implantation of decellularized muscles supports muscle regeneration in volumetric muscle loss models, including nervous system and neuromuscular junctional homing. Since the nervous system plays pivotal roles during skeletal muscle regeneration and in tissue homeostasis, support of reinnervation is a crucial aspect to be considered. However, the effect of decellularized muscles on reinnervation and on neuronal axon growth has been poorly investigated. Here, we characterized residual protein composition of decellularized muscles by mass spectrometry and we show that scaffolds preserve structural proteins of the ECM of both skeletal muscle and peripheral nervous system. To investigate whether decellularized scaffolds could per se attract neural axons, organotypic sections of spinal cord were cultured three dimensionally in vitro, in presence or in absence of decellularized muscles. We found that neural axons extended from the spinal cord are attracted by the decellularized muscles and penetrate inside the scaffolds upon 3D coculture. These results demonstrate that decellularized scaffolds possess intrinsic neurotrophic properties, supporting their potential use for the treatment of clinical cases where extensive functional regeneration of the muscle is required.
Keywords: 3D culture, axons, decellularized muscle, ECM, innervation, neurons, organotypic culture, spinal cord
Decellularized muscles show direct neurotrophic properties. Here, we developed a three‐dimensional in vitro model in which organotypic sections of fetal spinal cord were cultured in presence or in absence of decellularized muscles. Decellularized muscles, which proteomic composition includes both myofibers and peripheral nerve components, sustained axon sprouting and attraction of neurons.
Significance statement.
Skeletal muscle decellularization allows the generation of natural scaffolds that retain the extracellular matrix mechanical integrity, biological activity, and three‐dimensional (3D) architecture of the native tissue. State‐of‐the‐art studies report the evidence of a pro‐innervation ability of decellularized muscles when implanted in in vivo models. It was found that decellularized muscles preserve extracellaral matrix proteins of both muscular and peripheral nervous systems. To investigate whether decellularized scaffolds could per se attract neural axons, organotypic sections of spinal cord were cultured three dimensionally in vitro, in the presence or absence of decellularized muscles. This study found that neural axons extended from the spinal cord are attracted by the decellularized muscles and penetrate inside the scaffolds upon 3D coculture. These results demonstrate that decellularized scaffolds possess intrinsic neurotrophic properties, supporting their potential use for the treatment of clinical cases where extensive functional regeneration of the muscle is required.
1. INTRODUCTION
Tissue engineering combines extracellular natural and/or synthetic scaffolds (biomaterials) with stem cells and growth factors for the development of regenerative medicine strategies and the treatment of diseased tissues. 1 Synthetic scaffolds have the advantage over natural biomaterials in that their structure, topography, and mechanical properties can be finely tuned to design an optimal environment for a particular biological application. 1 Despite incredible improvements have been achieved in biomaterial manufacturing, many challenges remain in preparing scaffolds that recapitulate in vitro, the complexity of the tissue microenvironment. The peculiar combination of the tissue‐specific extracellular matrix (ECM) biochemistry, biomechanics, and three‐dimensional (3D) organization cannot be fully reproduced in the lab. 2 , 3 , 4 Therefore, there has been increasing interest in using naturally derived ECM itself, as decellularized (decell) tissues or whole organs, where such complexity can instead be preserved. 5 , 6 , 7
The decellularization process removes cellular and nuclear content of the native tissue, while retaining ECM mechanical integrity, biological activity, and 3D architecture. 6 Decell scaffolds are highly biocompatible and show absence of rejection after allogeneic or xenogeneic transplantation. 8 Altogether, these properties make them an important and promising alternative biomaterial for the treatment of clinical cases as traumatic injuries, surgical ablations, and congenital malformations. 9 , 10 Indeed they have already been obtained from different organs and used for regenerative medicine strategies in animal models, as well as in clinical trials. 9 , 10
In particular, decell muscles have been shown to promote muscle regeneration in volumetric muscle loss models. 7 We recently developed perfusion methods for the generation of skeletal muscle scaffolds which retain 3D structural organization of the tissue, as well as ECM components and growth factors. Decell muscles were used as xenograft to promote tissue regeneration in a murine model of volumetric muscle loss, which also allowed innervation and regeneration of the neuromuscular junctions. 11 In agreement with this, other studies have demonstrated that, when implanted in vivo, decell muscles are not only able to restore muscle mass, but also trigger the regeneration of the nervous system with overall functional recovery. 12 , 13 Finally, it was recently reported that decell muscles guide nerve regrowth in a diaphragmatic hernia mouse model. 14
During in vivo peripheral nerve regeneration, injured axons are able to elongate into the distal nerve stump if they find a permissive substrate. This is mainly provided by trophic support from Schwann cells, connective cells, and ECM. Eventually, regenerating axons will be mostly able to reach the distal target organs and reinnervate them, thus allowing for the recovery of lost functions. 15 , 16 The ECM is an essential player required for the formation of axonal tracts as well as for the maturation and function of synapses in the peripheral nervous system. 16 , 17 , 18 , 19 , 20 As extensively demonstrated by in vitro studies and tissue engineering strategies, axonal regrowth and guidance are enhanced by ECM components, including collagen IV or laminin. 16 , 17 , 18 , 19 , 20 In agreement with this, decell scaffolds prepared from nervous system‐derived tissues (including decell nerves) have been proved to support long‐distance axon regeneration in peripheral nerve injury in animal models 21 , 22 , 23 , 24 as well as in patients. 25 , 26 , 27
Other decell tissues used for nerve repair in in vivo models include scaffolds derived from small intestinal submucosa, 28 amniotic tissue grafts, 29 , 30 and umbilical cord. 31 Few studies also reported the ability of implanted decell muscles to repair nerve injury in vivo 27 , 32 , 33 , 34 , 35 .
The evidence that decell muscles promote myogenesis have been observed both in in vivo and in vitro models, indicating that these scaffolds directly preserve biological activity able to guide myogenic cells toward the generation of myofibers. 12 , 36 On the contrary, innervation of decell muscles has only been observed in in vivo models. 11 , 12 , 14 Therefore, it remains unclear whether the neurotrophic properties of the scaffolds observed in vivo could be the result of the overall regenerative response to the implant, or if decell muscle could directly promote axon invasion. The implementation of the nervous system is essential for skeletal muscle tissue functionality, which is a necessary feature for the future use of decell muscles in clinical application and 3D in vitro modeling. The purpose of this study was, therefore, to investigate the direct ability of decell scaffolds to promote axonal sprouting and invasion in vitro. To do so, we developed a 3D coculture system of organotypic spinal cord slides (oSpC) and decell muscles. This experimental approach allows the study of the neurotrophic effect of the scaffolds by excluding the influence of other cellular and/or systemic components that instead exist in vivo.
2. MATERIALS AND METHODS
2.1. Animals
For decellularized muscle preparation, 250 to 350 g male or female Sprague Dawley rats were used; all the procedures performed on animals were in accordance with Animals (Scientific Procedures) Act 1986. For spinal cord cultures, E14 fetuses were derived from pregnant Sprague Dawley rats purchased from Charles River Laboratories; all the procedures performed on animals were in accordance with Italian National laws and policies (D.L. n. 26, 14 March 2014), with the guidelines established by the European Community Council Directive (2010/63/EU), and were approved by the Italian Ministry of Health (authorization number: 81/2017 PR).
2.2. Decellularized muscle preparation
Rats (250‐350 g) were used as a source of muscle for decellularization. The leg was dissected from the rest of the body by splitting the pelvis at the pubic symphysis and the sacroiliac joint. We performed decellularization as previously described. 11 Briefly, a 24 G cannula was inserted into the abdominal iliac artery and advanced distally to allow perfusion condition at a flow rate of 1 mL/min. Limbs were perfused with 0.25% SDS (Sigma) for 72 hours and washed in deionized water for 48 hours. After decellularization, the muscles of interest were dissected, treated with 137Cesium irradiator (IBL 437C), and preserved at 4°C, in phosphate buffered saline (PBS, Gibco) with 1% Penicillin/Streptomycin (P/S, Gibco).
2.3. Proteomic sample preprocessing
The decellularized matrix was freeze‐dried for 72 hours (Labconco FreeZone Triad Freeze Dry Systems), milled into a thin powder using a mini‐mill (Thomas Wiley, mesh 40), and then lyophilized. The lyophilized decell powder batches, derived from three decellularization processes, were resuspended in 4% SDS (Sigma‐Aldrich). Protein extraction was performed by heating at 90°C for 10 minutes, and centrifuging at maximum velocity for 10 minutes at 4°C. Extracted proteins were reduced in 0.1 M dithiothreitol (DTT) at 95°C for 5 minutes, dissolved in 8 M urea solution after cooling down to room temperature (RT), alkylated with 55 mM iodoacetamide for 30 minutes at 25°C in the dark. Alkylated proteins were purified using Microcon YM‐10 filter unit (MRCPRT010, Millipore) eight times at 14 000g for 40 minutes followed by trypsin (Promega) digestion for 16 hours at 37°C. Digested peptides were eluted with 100 mM TEAB buffer three times, followed by desalting and vacuum drying. One hundred micrograms of peptides were labeled by 6‐plex Tandem Mass Tag (TMT, Thermo Fisher Scientific) according to manufacturer's instructions and resuspended in 30 μL 0.1% acetic acid for the following mass spectrometry analysis.
2.4. Proteomic liquid chromatography‐tandem mass spectrometry analysis
Protein identification by liquid chromatography tandem mass spectrometry (LC‐MS/MS) was performed using Thermo Fusion Mass Spectrometer with Thermo Easy‐nLC1000 Liquid Chromatography. Ninety minutes of LC‐MS gradients were generated by mixing buffer A (0.1% formic acid in water) with buffer B (0.1% formic acid in 80% acetonitrile (ACN) in water) by different proportions. Using nanospray ionization (NSI) as the ion source and Orbitrap as the detector, the mass scan Rang was at 300 to 1800 m/z, and the resolution was set to 120 K. The MS/MS was isolated by Quadrupole and detected by Ion trap, whose resolution was set to 60 K. The activation type was higher‐energy collisional dissociation (HCD).
2.5. Proteomic bioinformatics analysis
Peak list files were searched against UniProt Mus musculus reference proteome by Thermo Proteome Discoverer 2.2, due to the high similarity but more complete annotation of this proteome respect to that of Rattus norvegicus (Figure S1). Searches were performed using a 10 ppm precursor ion tolerance for total protein level profiling. The product ion tolerance was set to 0.02 Da in mascot TMT6 quantification searches. TMT6 modification (229.163 Da) and carbamidomethyl on cysteine (+57.021 Da) were set as static modifications. The oxidation of methionine residues (+15.995 Da) was set as a variable modification. Peptide‐spectrum matches were adjusted to a 1% and then assembled further to a final protein‐level false discovery rate of 1%. Proteins not identified in all three replicates or identified with a q‐value >0.05 were filtered out. Protein localization was annotated according to the following gene sets: matrisome (structural and associated), 37 extracellular vesicle (GO‐CC:1903561), membrane (GO‐CC:0016020), cytoskeleton (GO‐CC:0005856), and mitochondrion (GO‐CC:0005739). Protein classification by tissue was performed by comparison with data from ProteomicsDB (a mass spectrometry‐based proteomic annotation of human tissues) 38 for all tissues a part for skeletal muscle (not present) whose protein composition was obtained from the results of the Human Skeletal Muscle Proteome Project. 39 ECM structural proteins from this study were searched in String database 40 for their known interactions according to experimental evidence or curated databases. The resulting network was exported and graphically plotted in Cytoscape v. 3.7.1.
2.6. Organotypic spinal cord 3D culture
Isolated SpC were cut in three sections (apical, central, and caudal; ~1 × 1 × 2 mm) and cultured within 5 μL drop of 100% Matrigel Growth Factor Reduced (Corning 354 230) casted onto glass coverslip. For oSpC 3D culture onto decell muscles, scaffolds were cut in ~1 × 2 × 4 mm sections and put on a glass coverslip; then a single oSpC section was added onto each scaffold section and covered by 10 μL Matrigel droplet. To evaluate neural attractant effects of decell muscles, SpC sections were placed side by side with scaffold or with a sterile hydrophilic cotton gauze (~1 × 1 × 2 mm) onto a glass coverslip; 15 μL Matrigel droplet was used to embed the samples. The inert and decell scaffolds were placed approximately the same distance from each other (~1.5 mm) using a millimeter grid that was located under the petri dish at the moment of seeding. Samples were cultured in Neurobasal medium (Gibco 21 103 049), B‐27 supplement (Gibco 17 504 044) 1X, 2% Horse serum (Gibco 16 050 122), 0.5 mM GlutaMAX Supplement (Gibco 35 050 038), 25 μM 2‐Mercaptoethanol (Gibco 31 350 010), 25 μM L‐Glutamic acid (Sigma G5889), Gentamicin/Amphotericin (Gibco R01510), 10 ng/mL ciliary neurotrophic factor (CNTF, PeproTech 450‐13), and 10 ng/mL glial‐cell‐line‐derived neurotrophic factor (GDNF, Peprotech 450‐10). oSpC sections were maintained in culture for 14 days. Half medium was changed every 4 days.
2.7. Cell viability assay
Viability assay was performed using Calcein, AM (LifeTechnologies, C3099). Samples were washed twice in PBS and incubated for 30 minutes with 3 μM Calcein, AM (LifeTechnologies, C3099) in medium without serum. After Calcein staining, samples were washed twice in PBS and analyzed under fluorescence stereomicroscope Leica MZ16F and/or two‐photon microscope (Thorlabs or Scientifica).
2.8. Immunofluorescence
Samples were fixed in 3% paraformaldehyde for 45 minutes, washed twice in PBS, and analyzed in whole‐mount or in 20 μm longitudinal and cross‐sections. Samples were blocked and permeabilized in blocking solution, 0.5% Triton (Sigma) and 1% bovine serum albumin (Gibco) in PBS, for 2 hours at room temperature. Samples were incubated with primary antibody for 24 hours (whole‐mount) or overnight (sections) at 4°C, washed in PBS, and incubated with secondary antibodies for 2 hours at room temperature. The following primary antibodies resuspended in blocking solution were used: Rat anti‐α‐Laminin (Sigma, L0663) 1:100; Rabbit anti‐Laminin (Sigma, L9393) 1:100; Mouse anti‐βIII‐Tubulin (Tuj1—Biolegend, 801 202) 1:5000; Rabbit anti‐βIII‐Tubulin (Tuj1—SYSY, 302302) 1:500; Goat anti‐GFAP (Abcam, ab53554) 1:1000; Goat anti‐ChAT (Millipore, AB144P) 1:50; Rabbit anti NeuN (Abcam, ab104225) 1:500; Mouse anti‐Neurofilament H (NF‐H, Biolegend, 801 602) 1:200; Rabbit anti‐S100 beta (Abcam, ab52642) 1:100; Mouse anti‐Nkx6.1 (DSHB, F55A10) 1:25; Mouse anti‐ISL1/2 (DSHB, 39.4D5) 1:25. The following secondary antibodies diluted in blocking solution were used: Donkey anti‐mouse 488 (ThermoFisher, A21202) 1:200; Donkey anti‐rabbit 488 (ThermoFisher, A21206) 1:200; Donkey anti‐mouse 594 (ThermoFisher, A21203) 1:200; Donkey anti‐rabbit 594 (ThermoFisher, A31573) 1:200); Goat anti‐Rat Cy2 (Jackson, 112‐225‐167) 1:100; Donkey anti‐goat Cy3 (Jackson, 705‐165‐147). An amount of 10 μg/mL Hoechst 33342 (ThermoFisher, H1399) was used to stain nuclei.
2.9. Imaging acquisition and analysis
Samples were analyzed with the following microscopes: epi‐fluorescence Olympus BX60; fluorescence stereomicroscope Leica MZ16F, equipped with Canon EOS1000D camera; confocal Leica TCS SP5 microscope; confocal ZEISS LSM 800 microscope; wide‐field motorized stage Leica DM6B; modular multiphoton microscope (Bergano‐II, Thorlabs) coupled with two synchronized pulsed laser beams (excitation 800 nm). ImageJ software was used for image processing, contrast and intensity level adjustment, and 3D reconstruction. For directionality analysis, Directionality ImageJ plugin was used to analyze bright field images of the region between the oSpC and the scaffolds or the axons sprouting from the oSpC in absence of scaffolds. The plugin measured the amount of structures in a given direction every 2° (from −90° to +90°), where scaffolds were placed at 0° axis. Images with completely isotropic content are expected to give a flat histogram, whereas images in which there is a preferred orientation are expected to give a histogram with a peak at that orientation. The quantification was expressed as the mean of 4 to 6 independent biological replicates.
2.10. Statistical analysis
All the analyses were performed by using GraphPad Prism 6 software. Plotted data were expressed as mean ± SEM. We determined statistical significance by unequal variance Student's t test or one‐way ANOVA (analysis of variance) and Tukey's multiple comparison test or Kruskal‐Wallis and Dunn's multiple comparison test. A P value of less than .05 was considered statistically significant.
3. RESULTS
Based on the cell instructive cue exerted by decell muscles upon implantation in volumetric muscle loss models 11 and on the role of ECM during innervation, 16 , 17 , 18 , 19 , 20 we first characterized the residual protein composition of decell scaffolds by mass spectrometry. After applying stringent filtering criteria, we identified 2081 proteins (Table S1). At the protein level, our results indicate that decell muscles are not only composed by structural ECM proteins, but these includes also numerous other associated proteins (Figure 1A). In detail, we identified 72 ECM structural proteins (including collagens, laminins, fibronectin, nidogen‐1 and ‐2, and proteoglycans) and 46 ECM‐associated proteins (Figure 1A and Table S2). Within the latter category, multiple proteases and other ECM remodeling enzymes were included. Among these, we identified cathepsins, a disintegrin, ADAM family metalloproteases (Adam10 and Adamtsl4), and protease inhibitors (as Serpineb1a, Serpineb6, Serpine2, Serpinf1, Serpinh1). We already demonstrated that decell muscles preserve single anucleated myofibers (that could also be isolated) and sarcolemmal proteins such as dystroglycans. 11 Here, we confirmed these findings, identifying cytoskeleton proteins (including myosins, actins, and desmin) and sarcolemma proteins (GO‐CC: 0042383), including dysferlin (Dysf) and aquaporins (Aqp1, Aqp4 and Dag1) with its interacting partners (such as Lama2, Dmd, and Cav3; Figure 1A and Table S1). Direct associations between mitochondria and the cytoskeleton exist in myofibers. 41 In agreement with this, proteins known to be involved in mitochondria motility along microtubules such as dyneins, dynactins, and kinesins were preserved (Figure 1A and Table S1). We also revealed proteins composing extracellular vesicles in decell muscles (Figure 1A and Table S1). Interestingly, the identification of proteins involved in the ECM remodeling or composing extracellular vesicles strengthen the concept that decell muscle retains biological cues typical of the native tissue.
To determine the tissue‐specificity of protein content preserved in decell scaffolds, we compared our identified proteins to the curated protein composition of different tissues (Figure S1C,D). When we selected the proteins specific for each tissue, skeletal muscle was prevalent with approximately 10‐fold increase in the number of proteins among the tissues under consideration (Figure 1B). Moreover, we found that decell scaffolds preserved specific ECM proteins known to play a role in nerve regeneration and neurite outgrowth, as collagens (I, IV, VI), laminins (α2‐, α4‐, β1‐, and γ1‐chains), and fibronectin. 15 , 17 , 42 These proteins are known to be directly interacting with each other and form a well‐connected network (Figure 1C). Moreover, ECM components of nerves, such as myelin constituents (including myelin basic protein, Mbp, myelin P2 protein, Pmp2, and myelin proteolipid protein, Plp1), and specific ECM proteins of the synaptic basal lamina of neuromuscular junctions (including nidogen‐2, Nid2; laminin α4‐, α5‐ and α2‐chains) were also identified (Table S1 and S2). Altogether, these data support the hypothesis that decellularized muscles retain both muscular and neuronal tissue‐specific ECM components, including proteins that have been shown to drive nerve regeneration and promote neurite outgrowth.
To test whether decell muscles could have an intrinsic neurotrophic effect, scaffolds were cocultured with oSpCs in a 3D environment. The use of this culture system had the aim to retain 3D organization, multiple cell composition, and cell‐ECM interaction of neural cells within organotypic spinal cords, 43 , 44 as well as the specific skeletal muscle environment provided by the decell scaffolds. This strategy should allow to better mimic the in vivo innervation process, excluding the contribution of muscle regenerative and systemic responses (ie, inflammation) to the innervation process. In particular, we investigated the ability of decell scaffolds to sustain neural projection sprouting within its 3D environment by culturing oSpC in close proximity to the scaffolds or to attract neural axons when cocultured at a distance from each other.
To reach this aim, we first characterized 3D oSpC culture within Matrigel droplet in absence of the decell scaffolds. Fetal rat SpC were isolated and sectioned in three segments to approximately subdivide the cervical, thoracic, and lumbar/sacral regions. Each single section was then embedded in a Matrigel droplet and cultured up to 14 days. Incremental formation of cellular projections was observed in oSpC cultured in 3D from 2 to 14 days after seeding (Figures 2A and S2A). No differences in culture morphology were observed among oSpC derived from different anatomical regions (data not shown). Calcein uptake in the cellular bodies and projections of the 3D oSpC cultures confirmed the viability of the cells for 14 days (Figures 2A and S2). Interestingly, cellular projections were able to sprout from the SpC body in the 3D environment generated by the ECM constituting the Matrigel droplet (Figure 2B and Movie S1). Immunofluorescence analysis for neuron‐specific class III beta‐tubulin (Tuj1), neurofilament (NF‐H), Choline Acetyltransferase (ChAT), and neuronal nuclei (NeuN) confirmed the maintenance of cholinergic neurons over the cell culture and the axonal identity of the projections identified within the Matrigel (Figures 2C,D, S2C, and S3). The presence of Glial fibrillary acidic protein, localization of which was mainly restricted at the border of the oSpC body, demonstrated the maintenance of multiple cell types during the 3D culture (Figure S3B). Importantly, almost all the nuclei were identified in the body of the oSpC, with the presence of a few sparse cells located distantly from the oSpC body in the Matrigel droplet matrix (Figure S3).
Next, the oSpC was positioned in close proximity of the decell muscles, that is, onto the scaffolds. First, we used the Calcein incorporation assay to evaluate the oSpC viability upon culture on top of the decellularized scaffolds. Notably, 3D oSpC were vital after 14 days of culture, showing axons that run from the central body of the oSpC over the decell muscles (Figure 3A,B and Movie S2). Also, in the presence of decell muscles, the majority of the cell bodies remained localized within the oSpC and only a few cells were found in a distant position over the scaffolds during the culture (Figure 3). To confirm the neuronal nature of such cellular projections, oSpC cultured onto decell scaffolds were analyzed in whole‐mount via immunostaining (Figure 3C). Consistently with what observed in the absence of decellularized muscles, two‐photon imaging confirmed that neurons within oSpC extend their projections over the decell muscle. The surface of the decell muscles was identified by staining for laminin (ECM component of the muscle basal lamina). To better investigate whether such axons were able to grow within the scaffold, samples were cryo‐sectioned and subjected to immunofluorescence. Analysis performed at different regions of the coculture (middle or distal in respect to the oSpC body) demonstrated that axons were not only confined to the surface of decell muscles, but were also able to invade the ECM, penetrating within the scaffolds and localizing in close proximity to laminin (Figure 3D,E). Further immunofluorescence analysis for the members of the LIM homeodomain (LIM‐HD) transcription factor family Isl1 and Isl2, the homeobox protein Nkx6.1, and S100B confirmed that oSpC cultured onto decell scaffolds preserve a multicellular composition (Figure 4A‐C). Altogether these data demonstrated the ability of decell scaffolds to sustain neural survival and to allow axonal sprouting within their 3D environment.
When used in vivo to repair a resected muscle, decell scaffolds were permissive to innervation along the entire length of the implants. Importantly, this included the median region located far from the host tissue. 11 Therefore, we also hypothesized that the scaffolds could possess direct neuroattractant properties. To investigate this, oSpC were cocultured with decell muscles by seeding them at a distance from each other and embedding them in Matrigel droplets to allow a gel‐mediated physical connection (Figure 2A). Axonal spouting was monitored during the culture period at 4, 7, and 14 days after seeding (Figures 4D‐F and S5). We first quantified axon directionality, comparing oSpC culture performed in Matrigel droplets (a) in the absence of decellularized muscle, (b) in the presence of decellularized scaffolds, or (c) in the presence of inert scaffold. Four days after seeding, no preferential directions of the axons were observed in oSpC cultured within Matrigel or cocultured with inert scaffolds (Figure 4D,E). Conversely, marked orientation of axons was revealed in oSpC cocultured with decell muscles, with projections sprouting toward the decell muscles (Figure 4D,E). Based on these results, we also evaluated axon length 4 days after seeding. The presence of decell scaffolds did not influence significantly the length of neural projections, when compared to oSpC cultured in Matrigel or in the presence of inert scaffold (Figure S4). Moreover, the preferential organization of neural projections observed during the first days of culture was not appreciated anymore at longer time points, due to incremental sprouting in all the directions (Figure S5). Notably, projections of viable cells were present within the decell scaffold at 14 days after seeding, while nuclei were almost completely retained in the body of the oSpC. This was confirmed via two‐photon microscopy imaging of Calcein incorporating oSpC‐derived projections and by second‐harmonic generation imaging that revealed decell ECM (Figure 4F). These results indicate that decell scaffolds promote neural attraction during the early stages of the 3D coculture. Accordingly, projections sprout toward the scaffold also when oSpC and decell muscles are positioned at a distance from each other.
4. DISCUSSION
The perfusion process of decellularization allows for the maintenance of the native skeletal muscle complexity, 7 , 45 not only composed of myofibers, but also constituted by other structures such as peripheral nerves. Here, we show that upon decellularization, the skeletal muscle scaffold proteomic composition is much more complex than a mere network of structural ECM proteins associated with the myofibers.
Organotypic cultures of neural slides have been shown to represent a middle ground between dissociated cells and in vivo studies, and have been instrumental in enhancing our understanding of axon guidance. 43 , 44 The use of our 3D coculture system allowed to retain cell‐cell and cell‐matrix interactions and to investigate the direct neuro‐attractant effects of decell muscles, excluding other players that could instead operate in vivo during the regeneration of the implants. In particular, our model sustained the preservation of neurons expressing Isl1/2 and Nkx6.1, which are both markers required for motor neuron specification, 46 , 47 , 48 as well as neuronal cells expressing S100B, which is localized in many neural cell‐types, including astrocytes. 49
It is known that the ECM can either promote or inhibit the elongation of neurites and modulate axon growth. 16 , 17 , 18 , 19 , 20 For example, laminin is an adhesive component of the ECM secreted by Schwann cells. Laminin‐rich basal lamina scaffolds have shown pro‐regenerative capability following nerve injury, promoting axonal outgrowth in vitro 15 , 16 . Moreover, studies aiming at using decell tissues to repair peripheral nerve injuries suggested that the basal lamina of implanted decell scaffolds (that includes collagen type IV, fibronectin, and laminins) could mimic the endoneurial tube, thus promoting in vivo nerve outgrowth and nerve regeneration. 27 Our proteomic analysis of decell muscles confirmed the preservation of ECM proteins involved in axon growth (such as collagens, laminins, and fibronectin), as well as components of the peripheral nerves such as myelin constituents. Therefore, we can speculate that the observed ability of axons to sprout over and within the scaffolds could be the result of a physical guidance exerted by the structural and molecular composition of the ECM preserved in decell muscle.
Furthermore, the ability of decell muscles to attract neuronal axons strongly supports the hypothesis that the scaffolds have an intrinsic neurotrophic nature. The identification of the mechanism underpinning axon attraction from decell muscles remains an intriguing aspect that needs further investigation. However, the preservation of the signaling components in decell muscles strongly suggests that the scaffold could serve as a reservoir of neuro‐attractant molecules. Indeed, decell muscles preserved not only structural proteins of the ECM, but also extracellular vesicles and proteins involved in the ECM remodeling. Extracellular vesicles comprise a heterogeneous population of membrane vesicles with particular lipid, protein, and nucleic acid composition that are considered as an additional mechanism for intercellular communication, including the regulation of signal transduction and cell adhesion. 50 Interestingly, together with the presence of such signaling components, we also demonstrated that decell scaffolds preserve chemokines, such as vascular endothelial growth factor (VEGF) and insulin‐like growth factor (IGF‐1), abundance of which was estimated to be approximately 39 pg/mg wet decell tissue and 44 pg/mg wet decell tissue, respectively. 11 Both IGF‐1 and VEGF are neurotrophic factors that have been shown to promote peripheral nerve regeneration, axonal targeting and outgrowth, and to be protective in both in vitro and in vivo models of neuronal degeneration. 51 , 52 , 53 A number of studies have demonstrated that soluble factors released from the ECM and its degradation products themselves are capable of recruiting both neural differentiated cells and progenitors to the site of remodeling, 54 as well as Schwann cells from products derived from decellularized small intestinal submucosa. 55 It is, therefore, not unconceivable that signaling molecules could be released from the decell muscles during the time in culture, creating the chemotactic gradient, within the 3D culture system that promoted axonal sprouting toward the scaffolds.
5. CONCLUSION
Our study demonstrated that decell muscles obtained preserving the native tissue environment have direct neurotrophic properties. This strongly suggests that our model could represent a powerful tool to investigate in vitro axon sprouting and guidance within a complex native‐like skeletal muscle 3D environment. Finally, the increasing understanding of the neurotrophic properties of decell scaffolds can open new perspectives for tissue engineering approaches aimed at promoting in vivo reinnervation and functional skeletal muscle regeneration.
CONFLICT OF INTEREST
The authors declared no potential conflicts of interest.
AUTHOR CONTRIBUTIONS
P.R., V.S.: collection and assembly of data, data analysis and interpretation; M.F.M.G., S.P., P.D.C.: performed skeletal muscle decellularization; M.C., N.E., C.L.: performed proteomic data analysis and interpretation; P.C.: isolated fetal rat spinal cords; A.U.: conception and design, financial support, data analysis and interpretation, manuscript writing.
Supporting information
ACKNOWLEDGMENTS
This work was supported by STARS Starting Grant 2017 of University of Padova (Grant LS3‐19613) to A. U., P. R., and V. S. P. D. C., S. P., and M. F. M. G. were supported by the NHIR and CDH‐Sparks‐GOSH 16ICH03. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health are made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. M. F. M. G. work is funded through an H2020 Marie SkŁodowska‐Curie Individual Fellowship. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. M. C., N. E., and C. L. were supported by Grant F‐0301‐15‐009 of ShanghaiTech University. We are grateful to SIAIS Analytical Platform (Dr Wenzhang Chen and Dr Wei Zhu) at ShanghaiTech University for MS analyses support.
Raffa P, Scattolini V, Gerli MFM, et al. Decellularized skeletal muscles display neurotrophic effects in three‐dimensional organotypic cultures. STEM CELLS Transl Med. 2020;9:1233–1243. 10.1002/sctm.20-0090
Paolo Raffa and Valentina Scattolini contributed equally to this study.
Funding information STARS Starting Grant 2017 of University of Padova, Grant/Award Number: LS3‐19613; Shanghai Tech University, Grant/Award Number: F‐0301‐15‐009
DATA AVAILABILITY STATEMENT
All data are available in the main text or the Supporting Information and tables.
REFERENCES
- 1. Atala A, Lanza RP, Mikos AG, Nerem RM. Principles of Regenerative Medicine. London, UK: Academic Press; 2018. https://www.elsevier.com/books/principles‐of‐regenerative‐medicine/atala/978‐0‐12‐809880‐6 [Google Scholar]
- 2. Williams DF. Challenges With the Development of Biomaterials for Sustainable Tissue Engineering. Frontiers in Bioengineering and Biotechnology. 2019;7 10.3389/fbioe.2019.00127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195‐4200. 10.1242/jcs.023820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Humphrey JD, Dufresne ER, Schwartz MA. Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol. 2014;15:802‐812. 10.1038/nrm3896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Hillebrandt KH, Everwien H, Haep N, Keshi E, Pratschke J, Sauer IM. Strategies based on organ decellularization and recellularization. Transpl Int. 2019;32(6):571‐585. 10.1111/tri.13462. [DOI] [PubMed] [Google Scholar]
- 6. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006;27:3675‐3683. 10.1016/j.biomaterials.2006.02.014. [DOI] [PubMed] [Google Scholar]
- 7. Urciuolo A, De Coppi P. Decellularized tissue for muscle regeneration. Int J Mol Sci. 2018;19:2392. 10.3390/ijms19082392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Gilpin A, Yang Y. Decellularization strategies for regenerative medicine: from processing techniques to applications. Biomed Res Int. 2017;2017:1‐13. 10.1155/2017/9831534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Taylor DA, Sampaio LC, Ferdous Z, Gobin AS, Taite LJ. Decellularized matrices in regenerative medicine. Acta Biomater. 2018;74:74‐89. 10.1016/j.actbio.2018.04.044. [DOI] [PubMed] [Google Scholar]
- 10. Yu Y, Alkhawaji A, Ding Y, Mei J. Decellularized scaffolds in regenerative medicine. Oncotarget. 2016;7:58671‐58683. 10.18632/oncotarget.10945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Urciuolo A, Urbani L, Perin S, et al. Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration. Sci Rep. 2018;8:8398 10.1038/s41598-018-26371-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Kasukonis B, Kim J, Brown L, et al. Codelivery of infusion decellularized skeletal muscle with minced muscle autografts improved recovery from volumetric muscle loss injury in a rat model. Tissue Eng Part A. 2016;22:1151‐1163. 10.1089/ten.tea.2016.0134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Quarta M, Cromie M, Chacon R, et al. Bioengineered constructs combined with exercise enhance stem cell‐mediated treatment of volumetric muscle loss. Nat Commun. 2017;8:15613 10.1038/ncomms15613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Trevisan C, Maghin E, Dedja A, et al. Allogenic tissue‐specific decellularized scaffolds promote long‐term muscle innervation and functional recovery in a surgical diaphragmatic hernia model. Acta Biomater. 2019;89:115‐125. 10.1016/j.actbio.2019.03.007. [DOI] [PubMed] [Google Scholar]
- 15. Gonzalez‐Perez F, Udina E, Navarro X. Extracellular matrix components in peripheral nerve regeneration International Review of Neurobiology. Academic press; 2013;108:257‐275. 10.1016/B978-0-12-410499-0.00010-1. [DOI] [PubMed] [Google Scholar]
- 16. de Luca AC, Lacour SP, Raffoul W, di Summa PG. Extracellular matrix components in peripheral nerve repair: how to affect neural cellular response and nerve regeneration. Neural Regen Res. 2014;9:1943‐1948. 10.4103/1673-5374.145366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Alovskaya A, Alekseeva T, Phillips JB, King V, Brown R. Fibronectin, collagen, fibrin‐components of extracellular matrix for nerve regeneration Topics in Tissue Engineering. 2007;3:1‐27. http://oro.open.ac.uk/9064/. [Google Scholar]
- 18. Barros CS, Franco SJ, Muller U. Extracellular matrix: functions in the nervous system. Cold Spring Harb Perspect Biol. 2011;3:a005108 10.1101/cshperspect.a005108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Quraishe S, Forbes LH, Andrews MR. The extracellular environment of the CNS: influence on plasticity, sprouting, and axonal regeneration after spinal cord injury. Neural Plast. 2018;2018:1‐18. 10.1155/2018/2952386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Sanes JR. The basement membrane/basal lamina of skeletal muscle. J Biol Chem. 2003;278:12601‐12604. 10.1074/jbc.R200027200. [DOI] [PubMed] [Google Scholar]
- 21. Sedaghati T, Jell G, Seifalian AM. Nerve regeneration and bioengineering Regenerative Medicine Applications in Organ Transplantation. Academic Press; 2014:799‐810. 10.1016/B978-0-12-398523-1.00057-4. [DOI] [Google Scholar]
- 22. Zhao Z, Wang Y, Peng J, et al. Improvement in nerve regeneration through a decellularized nerve graft by supplementation with bone marrow stromal cells in fibrin. Cell Transplant. 2014;23:97‐110. 10.3727/096368912X658845. [DOI] [PubMed] [Google Scholar]
- 23. Lovati AB, D'Arrigo D, Odella S, Tos P, Geuna S, Raimondo S. Nerve repair using decellularized nerve grafts in rat models. A review of the literature. Front Cell Neurosci. 2018;12:1‐20. 10.3389/fncel.2018.00427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Szynkaruk M, Kemp SWP, Wood MD, Gordon T, Borschel GH. Experimental and clinical evidence for use of decellularized nerve allografts in peripheral nerve gap reconstruction. Tissue Eng Part B Rev. 2013;19:83‐96. 10.1089/ten.teb.2012.0275. [DOI] [PubMed] [Google Scholar]
- 25. Carriel V, Alaminos M, Garzón I, Campos A, Cornelissen M. Tissue engineering of the peripheral nervous system. Expert Rev Neurother. 2014;14:301‐318. 10.1586/14737175.2014.887444. [DOI] [PubMed] [Google Scholar]
- 26. Brooks DN, Weber RV, Chao JD, et al. Processed nerve allografts for peripheral nerve reconstruction: a multicenter study of utilization and outcomes in sensory, mixed, and motor nerve reconstructions. Microsurgery. 2012;32:1‐14. 10.1002/micr.20975. [DOI] [PubMed] [Google Scholar]
- 27. Johnson PJ, Wood MD, Moore AM, Mackinnon SE. Tissue engineered constructs for peripheral nerve surgery. Eur Surg. 2013;45:122‐135. 10.1007/s10353-013-0205-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Hadlock TA, Sundback CA, Hunter DA, Vacanti JP, Cheney ML. A new artificial nerve graft containing rolled Schwann cell monolayers. Microsurgery. 2001;21:96‐101. 10.1002/micr.1016. [DOI] [PubMed] [Google Scholar]
- 29. Davis GE, Blaker SN, Engvall E, Varon S, Manthorpe M, Gage FH. Human amnion membrane serves as a substratum for growing axons in vitro and in vivo. Science. 1987;236:1106‐1109. 10.1126/science.3576223. [DOI] [PubMed] [Google Scholar]
- 30. Mohammad JA, Warnke PH, Pan YC, Shenaq S. Increased axonal regeneration through a biodegradable amnionic tube nerve conduit: effect of local delivery and incorporation of nerve growth factor/hyaluronic acid media. Ann Plast Surg. 2000;44:59‐64. 10.1097/00000637-200044010-00010. [DOI] [PubMed] [Google Scholar]
- 31. Kočí Z, Výborný K, Dubišová J, et al. Extracellular matrix hydrogel derived from human umbilical cord as a scaffold for neural tissue repair and its comparison with extracellular matrix from porcine tissues. Tissue Eng Part C Methods. 2017;23:333‐345. 10.1089/ten.tec.2017.0089. [DOI] [PubMed] [Google Scholar]
- 32. Fansa H, Schneider W, Wolf G, Keilhoff G. Host responses after acellular muscle basal lamina allografting used as a matrix for tissue engineered nerve grafts. Transplantation. 2002;74:381‐387. 10.1097/00007890-200208150-00015. [DOI] [PubMed] [Google Scholar]
- 33. Mligiliche N, Kitada M, Ide C. Grafting of detergent‐denatured skeletal muscles provides effective conduits for extension of regenerating axons in the rat sciatic nerve. Arch Histol Cytol. 2001;64:29‐36. 10.1679/aohc.64.29. [DOI] [PubMed] [Google Scholar]
- 34. Liu X‐L, Arai T, Sondell M, Lundborg G, Kanje M, Dahlin LB. Use of chemically extracted muscle grafts to repair extended nerve defects in rats. Scand J Plast Reconstr Surg Hand Surg. 2001;35:337‐345. 10.1080/028443101317149291. [DOI] [PubMed] [Google Scholar]
- 35. Meek MF, Varejão ASP, Geuna S. Use of skeletal muscle tissue in peripheral nerve repair: review of the literature. Tissue Eng. 2004;10:1027‐1036. 10.1089/ten.2004.10.1027. [DOI] [PubMed] [Google Scholar]
- 36. Trevisan C, Fallas MEA, Maghin E, et al. Generation of a functioning and self‐renewing diaphragmatic muscle construct. Stem Cells Translational Medicine. 2019;8:858‐869. 10.1002/sctm.18-0206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics. 2012;11:M111.014647 10.1074/mcp.M111.014647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Wilhelm M, Schlegl J, Hahne H, et al. Mass‐spectrometry‐based draft of the human proteome. Nature. 2014;509:582‐587. 10.1038/nature13319. [DOI] [PubMed] [Google Scholar]
- 39. Gonzalez‐Freire M, Semba RD, Ubaida‐Mohien C, et al. The human skeletal muscle proteome project: a reappraisal of the current literature. J Cachexia Sarcopenia Muscle. 2017;8:5‐18. 10.1002/jcsm.12121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality‐controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362‐D368. 10.1093/nar/gkw937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Moore AS, Holzbaur ELF. Mitochondrial‐cytoskeletal interactions: dynamic associations that facilitate network function and remodeling. Curr Opin Physiol. 2018;3:94‐100. 10.1016/j.cophys.2018.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Gregorio I, Braghetta P, Bonaldo P, Cescon M. Collagen VI in healthy and diseased nervous system. Dis Model Mech. 2018;11:dmm032946 10.1242/dmm.032946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Al‐Ali H, Beckerman SR, Bixby JL, Lemmon VP. In vitro models of axon regeneration. Exp Neurol. 2017;287:423‐434. 10.1016/j.expneurol.2016.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Pandamooz S, Nabiuni M, Miyan J, Ahmadiani A, Dargahi L. Organotypic spinal cord culture: a proper platform for the functional screening. Mol Neurobiol. 2016;53:4659‐4674. 10.1007/s12035-015-9403-z. [DOI] [PubMed] [Google Scholar]
- 45. Gerli MFM, Guyette JP, Evangelista‐Leite D, Ghoshhajra BB, Ott HC. Perfusion decellularization of a human limb: a novel platform for composite tissue engineering and reconstructive surgery. PLoS One. 2018;13:e0191497 10.1371/journal.pone.0191497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Pfaff SL, Mendelsohn M, Stewart CL, Edlund T, Jessell TM. Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron– dependent step in interneuron differentiation. Cell. 1996;84:309‐320. 10.1016/S0092-8674(00)80985-X. [DOI] [PubMed] [Google Scholar]
- 47. Thaler JP, Koo SJ, Kania A, et al. A postmitotic role for Isl‐class LIM homeodomain proteins in the assignment of visceral spinal motor neuron identity. Neuron. 2004;41:337‐350. 10.1016/S0896-6273(04)00011-X. [DOI] [PubMed] [Google Scholar]
- 48. Briscoe J, Pierani A, Jessell TM, Ericson J. A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell. 2000;101:435‐445. 10.1016/S0092-8674(00)80853-3. [DOI] [PubMed] [Google Scholar]
- 49. Donato R, Sorci G, Riuzzi F, et al. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta. 2009;1793:1008‐1022. 10.1016/j.bbamcr.2008.11.009. [DOI] [PubMed] [Google Scholar]
- 50. van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213‐228. 10.1038/nrm.2017.125. [DOI] [PubMed] [Google Scholar]
- 51. Sullivan KA, Kim B, Feldman EL. Insulin‐like growth factors in the peripheral nervous system. Endocrinology. 2008;149:5963‐5971. 10.1210/en.2008-1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organogenesis. 2010;6:107‐114. 10.4161/org.6.2.11687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Gouel F, Rolland A‐S, Devedjian J‐C, Burnouf T, Devos D. Past and future of neurotrophic growth factors therapies in ALS: from single neurotrophic growth factor to stem cells and human platelet lysates. Front Neurol. 2019;10:1‐11. 10.3389/fneur.2019.00835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Reing JE, Zhang L, Myers‐Irvin J, et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A. 2009;15:605‐614. 10.1089/ten.tea.2007.0425. [DOI] [PubMed] [Google Scholar]
- 55. Agrawal V, Brown BN, Beattie AJ, Gilbert TW, Badylak SF. Evidence of innervation following extracellular matrix scaffold‐mediated remodelling of muscular tissues. J Tissue Eng Regen Med. 2009;3:590‐600. 10.1002/term.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are available in the main text or the Supporting Information and tables.